OA09884A - Imidazolyl-Alkenoic Acids - Google Patents
Imidazolyl-Alkenoic AcidsInfo
- Publication number
- OA09884A OA09884A OA60471A OA60471A OA09884A OA 09884 A OA09884 A OA 09884A OA 60471 A OA60471 A OA 60471A OA 60471 A OA60471 A OA 60471A OA 09884 A OA09884 A OA 09884A
- Authority
- OA
- OAPI
- Prior art keywords
- imidazolyl
- alkenoic acids
- alkenoic
- acids
- Prior art date
Links
- 239000002253 acid Substances 0.000 title 1
- 150000007513 acids Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Ophthalmology & Optometry (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/746,262 US5185351A (en) | 1989-06-14 | 1991-08-14 | Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA09884A true OA09884A (en) | 1994-09-15 |
Family
ID=25000103
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| OA60471A OA09884A (en) | 1991-08-14 | 1994-02-10 | Imidazolyl-Alkenoic Acids |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US5185351A (show.php) |
| EP (1) | EP0641203B1 (show.php) |
| JP (1) | JPH07500579A (show.php) |
| CN (1) | CN1036396C (show.php) |
| AP (3) | AP527A (show.php) |
| AT (1) | ATE226073T1 (show.php) |
| AU (1) | AU667824B2 (show.php) |
| BG (1) | BG61593B1 (show.php) |
| BR (1) | BR9206443A (show.php) |
| CA (1) | CA2115170C (show.php) |
| CZ (1) | CZ281635B6 (show.php) |
| DE (1) | DE69232817T2 (show.php) |
| DK (1) | DK0641203T3 (show.php) |
| ES (1) | ES2185617T3 (show.php) |
| FI (1) | FI114796B (show.php) |
| HU (1) | HU225048B1 (show.php) |
| IL (1) | IL102813A (show.php) |
| MA (1) | MA22626A1 (show.php) |
| MX (1) | MX9204737A (show.php) |
| MY (1) | MY110205A (show.php) |
| NO (1) | NO305172B1 (show.php) |
| NZ (1) | NZ243966A (show.php) |
| OA (1) | OA09884A (show.php) |
| PL (1) | PL177234B1 (show.php) |
| PT (1) | PT100779B (show.php) |
| RO (1) | RO113643B1 (show.php) |
| RU (1) | RU2124513C1 (show.php) |
| SK (1) | SK281252B6 (show.php) |
| TW (1) | TW234690B (show.php) |
| UA (1) | UA40587C2 (show.php) |
| WO (1) | WO1993003722A1 (show.php) |
| ZA (1) | ZA926133B (show.php) |
Families Citing this family (81)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5185351A (en) * | 1989-06-14 | 1993-02-09 | Smithkline Beecham Corporation | Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists |
| US5418250A (en) * | 1989-06-14 | 1995-05-23 | Smithkline Beecham Corporation | Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists |
| WO1992010189A1 (en) * | 1990-12-14 | 1992-06-25 | Smithkline Beecham Corporation | Imidazolyl-alkenoic acids |
| GB9027200D0 (en) * | 1990-12-14 | 1991-02-06 | Smithkline Beecham Plc | Medicaments |
| US6028091A (en) * | 1990-12-14 | 2000-02-22 | Smithkline Beecham Plc | Medicament |
| US6034114A (en) * | 1990-12-14 | 2000-03-07 | Smithkline Beecham Plc | Medicament |
| US6025380A (en) * | 1990-12-14 | 2000-02-15 | Smithkline Beecham Plc | Medicament |
| US5447949A (en) * | 1991-05-15 | 1995-09-05 | Smithkline Beecham Corporation | N-(heteroaryl) imidazolyl-alkenoic acids having angiotension II receptor antagonist activity |
| US20030166700A1 (en) * | 1991-12-12 | 2003-09-04 | Smithkline Beecham P.L.C. | Medicament |
| US5308853A (en) * | 1991-12-20 | 1994-05-03 | Warner-Lambert Company | Substituted-5-methylidene hydantoins with AT1 receptor antagonist properties |
| DE4206043A1 (de) * | 1992-02-27 | 1993-09-02 | Bayer Ag | Sulfonylbenzyl-substituierte imidazole |
| US5401851A (en) * | 1992-06-03 | 1995-03-28 | Eli Lilly And Company | Angiotensin II antagonists |
| US5824696A (en) * | 1993-09-01 | 1998-10-20 | Smithkline Beecham Corporation | Medicaments |
| US5395847A (en) * | 1993-12-02 | 1995-03-07 | Smithkline Beecham Corporation | Imidazolyl-alkenoic acids |
| MX9605794A (es) * | 1994-05-20 | 1997-12-31 | Smithkline Beecham Corp | Intermediario para preparar un compuesto farmaceuticamente activo. |
| CA2193966A1 (en) * | 1994-06-29 | 1996-01-11 | Fadia El-Fehail Ali | Vitronectin receptor antagonists |
| US5616601A (en) * | 1994-07-28 | 1997-04-01 | Gd Searle & Co | 1,2-aryl and heteroaryl substituted imidazolyl compounds for the treatment of inflammation |
| US6613789B2 (en) | 1994-07-28 | 2003-09-02 | G. D. Searle & Co. | Heterocyclo-substituted imidazoles for the treatment of inflammation |
| US5977101A (en) * | 1995-06-29 | 1999-11-02 | Smithkline Beecham Corporation | Benzimidazoles/Imidazoles Linked to a Fibrinogen Receptor Antagonist Template Having Vitronectin Receptor Antagonist Activity |
| WO1997036874A1 (en) * | 1996-03-29 | 1997-10-09 | Smithkline Beecham Corporation | Eprosartan dihydrate and a process for its production and formulation |
| US6420412B2 (en) | 1996-03-29 | 2002-07-16 | Smithkline Beecham Corporation | Eprosartan dihydate and a process for its production and formulation |
| AR011125A1 (es) * | 1997-02-14 | 2000-08-02 | Smithkline Beecham Corp | Procedimiento para preparar eprosartano |
| AR011126A1 (es) * | 1997-02-14 | 2000-08-02 | Smithkline Beecham Corp | Procedimiento para preparar eprosartano y compuestos intermediarios. |
| US20030045561A1 (en) * | 2001-02-06 | 2003-03-06 | Smithkline Beecham Corporation | Method of treating isolated systolic hypertension |
| ZA984421B (en) * | 1997-05-27 | 1998-11-27 | Smithkline Beecham Corp | Method of treating isolated systolic hypertension |
| JP4475685B2 (ja) | 1997-06-27 | 2010-06-09 | スミスクライン・ビーチャム・コーポレイション | エプロサルタン・一水和物 |
| US6630498B2 (en) | 1997-08-06 | 2003-10-07 | Smithkline Beecham Corporation | Eprosartan arginyl charge-neutralization-complex and a process for its preparation and formulation |
| WO1999007365A1 (en) * | 1997-08-06 | 1999-02-18 | Smithkline Beecham Corporation | Eprosartan arginyl charge-neutralization-complex and a process for its production and formulation |
| AU750611B2 (en) * | 1997-11-17 | 2002-07-25 | Smithkline Beecham Corporation | High drug load immediate and modified release oral dosage formulations and processes for their manufacture |
| US6558699B2 (en) * | 1997-11-17 | 2003-05-06 | Smithkline Beecham Corporation | High drug load immediate and modified release oral dosage formulations and processes for their manufacture |
| ZA991922B (en) * | 1998-03-11 | 1999-09-13 | Smithkline Beecham Corp | Novel compositions of eprosartan. |
| AU763309B2 (en) * | 1998-07-20 | 2003-07-17 | Smithkline Beecham Corporation | Bioenhanced formulations comprising eprosartan in oral solid dosage form |
| ES2237141T3 (es) | 1998-07-24 | 2005-07-16 | Bayer Cropscience Ag | Benzoilciclohexanodionas substituidas. |
| DE19920791A1 (de) | 1999-05-06 | 2000-11-09 | Bayer Ag | Substituierte Benzoylisoxazole |
| DE19921424A1 (de) | 1999-05-08 | 2000-11-09 | Bayer Ag | Substituierte Benzoylketone |
| DE19946853A1 (de) | 1999-09-30 | 2001-04-05 | Bayer Ag | Substituierte Arylketone |
| DE10004084A1 (de) * | 2000-01-31 | 2001-08-02 | Bayer Ag | Substituierte Imid-Derivate |
| DE10221121A1 (de) * | 2002-05-13 | 2003-12-04 | Bayer Cropscience Ag | N'-Cyano-N-methyl-imidamid-Derivate |
| OA12905A (en) | 2002-08-19 | 2006-10-13 | Pfizer Prod Inc | Combination therapy for hyperproliferative diseases. |
| AP1963A (en) * | 2003-05-30 | 2009-03-03 | Ranbaxy Lab Ltd | Substituted pyrrole derivatives and their use as HMG-co inhibitors |
| US20050037063A1 (en) * | 2003-07-21 | 2005-02-17 | Bolton Anthony E. | Combined therapies |
| DE602004012763T2 (de) * | 2003-10-10 | 2009-05-07 | Solvay Pharmaceuticals Gmbh | Pharmazeutische zusammensetzung mit einem selektiven i1 imidazolin-rezeptor-agonisten und einem angiotensin-ii-rezeptorblocker |
| US20060099230A1 (en) * | 2004-11-10 | 2006-05-11 | Chin-Chih Chiang | Novel formulations of eprosartan with enhanced bioavailability |
| BRPI0518300A2 (pt) * | 2004-11-23 | 2008-11-11 | Warner Lambert Co | derivados de Ácido 7-(2h-pirazol-3-il)-3,5-diidràxi-heptanàico como inibidores da hmg co-a reductase para o tratamento de lipidemia |
| EP1752450A1 (en) | 2005-08-01 | 2007-02-14 | Merck Sante | Imidazole derivatives as fructose-1,6-bisphosphatase inhibitors and pharmaceutical compositions containing them |
| US7741317B2 (en) | 2005-10-21 | 2010-06-22 | Bristol-Myers Squibb Company | LXR modulators |
| AU2006313430B2 (en) * | 2005-11-08 | 2012-09-06 | Ranbaxy Laboratories Limited | Process for (3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt |
| US7888376B2 (en) | 2005-11-23 | 2011-02-15 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
| CN101312962A (zh) * | 2005-12-06 | 2008-11-26 | 参天制药株式会社 | 角膜结膜病变的治疗剂 |
| AR059838A1 (es) * | 2006-03-14 | 2008-04-30 | Ranbaxy Lab Ltd | Formulaciones para dosis estabilizantes de estatina |
| MX2009000439A (es) * | 2006-07-14 | 2009-02-04 | Ranbaxy Lab Ltd | Formas polimorficas de un inhibidor de hmg-coa reductasa y usos de las mismas. |
| US20080014263A1 (en) * | 2006-07-17 | 2008-01-17 | Glenmark Pharmaceuticals Limited | Amorphous eprosartan mesylate and process for the preparation thereof |
| ATE547394T1 (de) | 2006-12-01 | 2012-03-15 | Bristol Myers Squibb Co | N-((3-benzyl)-2,2-(bis-phenyl)-propan-1- aminderivate als cetp-hemmer für die behandlung von atherosklerose und herz-kreislauf- erkrankungen |
| WO2008078330A1 (en) * | 2006-12-27 | 2008-07-03 | Hetero Drugs Limited | Improved process for eprosartan |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| US20100120694A1 (en) | 2008-06-04 | 2010-05-13 | Synergy Pharmaceuticals, Inc. | Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders |
| DK2170930T3 (da) | 2007-06-04 | 2012-11-05 | Synergy Pharmaceuticals Inc | Agonister af guanylatcyclase, anvendelige til behandlingen af gastrointestinale sygdomme, inflammation, cancer og andre sygdomme |
| WO2009013760A2 (en) * | 2007-07-25 | 2009-01-29 | Hetero Drugs Limited | Eprosartan mesylate crystalline particles and a process for preparing pure eprosartan |
| EP2295431A3 (en) * | 2007-07-25 | 2011-08-03 | Hetero Drugs Limited | Substantially pure eprosartan free base |
| NZ584845A (en) * | 2007-10-22 | 2011-09-30 | Orchid Res Lab Ltd | Histone deacetylase inhibitors |
| WO2009084028A2 (en) * | 2007-12-03 | 2009-07-09 | Neuland Laboratories Ltd | Improved process for manufacturing anhydrous (e)-3-[2-butyl-1- {(4-carboxyphenyl) methyl}-1h-imidazole-5-yl]-(thiophen-2- ylmethyl)prop-2-enoic acid methane sulfonate |
| CN101215284B (zh) * | 2007-12-31 | 2010-10-13 | 浙江华海药业股份有限公司 | 一种改进的依普罗沙坦的制备方法 |
| US20110054186A1 (en) * | 2008-03-31 | 2011-03-03 | Hetero Research Foundation | Process for eprosartan intermediate |
| CA2730603C (en) | 2008-07-16 | 2019-09-24 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| CN101333216A (zh) * | 2008-08-03 | 2008-12-31 | 浙江华海药业股份有限公司 | 一种新的依普罗沙坦甲磺酸盐成盐工艺 |
| US9387249B2 (en) | 2008-12-23 | 2016-07-12 | Takeda Pharmaceutical Company Limited | Methods of treating hypertension with at least one angiotensin II receptor blocker and chlorthalidone |
| WO2011004384A2 (en) | 2009-06-05 | 2011-01-13 | Glochem Industries Limited | Process for the preparation of eprosartan |
| WO2011051975A1 (en) | 2009-10-30 | 2011-05-05 | Matrix Laboratories Ltd | An improved process for the preparation of pure eprosartanand its pharmaceutical acceptable salts |
| AU2010328186B2 (en) | 2009-12-08 | 2014-12-18 | Case Western Reserve University | Compounds and methods of treating ocular disorders |
| RU2525156C2 (ru) * | 2010-07-15 | 2014-08-10 | Общество С Ограниченной Ответственностью "Научно-Производственная Фирма "Материа Медика Холдинг" | Способ лечения и профилактики артериальной гипертензии и фармацевтическая композиция для лечения артериальной гипертензии |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| RU2570752C2 (ru) | 2011-08-26 | 2015-12-10 | Вокхардт Лимитед | Способы лечения сердечно-сосудистых нарушений |
| US9486494B2 (en) | 2013-03-15 | 2016-11-08 | Synergy Pharmaceuticals, Inc. | Compositions useful for the treatment of gastrointestinal disorders |
| US9708367B2 (en) | 2013-03-15 | 2017-07-18 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase and their uses |
| SG11201507496UA (en) | 2013-04-17 | 2015-11-27 | Pfizer | N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases |
| AU2014274812B2 (en) | 2013-06-05 | 2018-09-27 | Bausch Health Ireland Limited | Ultra-pure agonists of guanylate cyclase C, method of making and using same |
| JP6422868B2 (ja) | 2013-07-23 | 2018-11-14 | 第一三共株式会社 | 高血圧症の予防又は治療のための医薬 |
| WO2016055901A1 (en) | 2014-10-08 | 2016-04-14 | Pfizer Inc. | Substituted amide compounds |
| CA3015964C (en) | 2016-03-24 | 2021-08-03 | Daiichi Sankyo Company, Limited | Medicine for treating renal disease |
| US11081240B2 (en) | 2018-06-14 | 2021-08-03 | Astrazeneca Uk Limited | Methods for treatment of hypertension with an angiotensin II receptor blocker pharmaceutical composition |
| PL3911648T3 (pl) | 2019-01-18 | 2025-03-10 | Astrazeneca Ab | 6'-[[(1s,3s)-3-[[5-(difluorometoksy)-2- pirymidynylo]amino]cyklopentylo]amino][1(2h),3'-bipirydyn]-2-on jako inhibitor pcsk9 i sposoby jego zastosowania |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5671073A (en) * | 1979-11-12 | 1981-06-13 | Takeda Chem Ind Ltd | Imidazole derivative |
| JPS5671074A (en) * | 1979-11-12 | 1981-06-13 | Takeda Chem Ind Ltd | 1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative |
| JPS58157768A (ja) * | 1982-03-16 | 1983-09-19 | Takeda Chem Ind Ltd | ４−クロロ−２−フエニルイミダゾ−ル−５−酢酸誘導体 |
| US4668794A (en) * | 1985-05-22 | 1987-05-26 | Sandoz Pharm. Corp. | Intermediate imidazole acrolein analogs |
| CA1334092C (en) * | 1986-07-11 | 1995-01-24 | David John Carini | Angiotensin ii receptor blocking imidazoles |
| CA1338238C (en) * | 1988-01-07 | 1996-04-09 | David John Carini | Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids |
| US5185351A (en) * | 1989-06-14 | 1993-02-09 | Smithkline Beecham Corporation | Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists |
| ATE250587T1 (de) * | 1989-06-14 | 2003-10-15 | Smithkline Beecham Corp | Imidazoalkensäure |
| AU640417B2 (en) * | 1989-10-25 | 1993-08-26 | Smithkline Beecham Corporation | Substituted 5-((tetrazolyl)alkenyl)imidazoles |
| GB9027197D0 (en) * | 1990-12-14 | 1991-02-06 | Smithkline Beecham Plc | Medicaments |
| GB9027201D0 (en) * | 1990-12-14 | 1991-02-06 | Smithkline Beecham Plc | Medicaments |
| GB9027198D0 (en) * | 1990-12-14 | 1991-02-06 | Smithkline Beecham Plc | Medicaments |
| GB9027208D0 (en) * | 1990-12-14 | 1991-02-06 | Smithkline Beecham Plc | Medicaments |
| GB9027200D0 (en) * | 1990-12-14 | 1991-02-06 | Smithkline Beecham Plc | Medicaments |
| GB9027210D0 (en) * | 1990-12-14 | 1991-02-06 | Smithkline Beecham Plc | Medicaments |
| GB9027212D0 (en) * | 1990-12-14 | 1991-02-06 | Smithkline Beecham Plc | Medicaments |
| GB9027209D0 (en) * | 1990-12-14 | 1991-02-06 | Smithkline Beecham Plc | Medicaments |
| GB9027199D0 (en) * | 1990-12-14 | 1991-02-06 | Smithkline Beecham Plc | Medicaments |
| WO1992010189A1 (en) * | 1990-12-14 | 1992-06-25 | Smithkline Beecham Corporation | Imidazolyl-alkenoic acids |
| GB9027211D0 (en) * | 1990-12-14 | 1991-02-06 | Smithkline Beecham Plc | Medicaments |
| JP3398379B2 (ja) * | 1990-12-14 | 2003-04-21 | スミスクライン・ビーチャム・コーポレイション | アンジオテンシンｉｉ受容体遮断組成物 |
-
1991
- 1991-08-14 US US07/746,262 patent/US5185351A/en not_active Expired - Lifetime
-
1992
- 1992-08-12 RU RU94018226A patent/RU2124513C1/ru active
- 1992-08-12 UA UA94021675A patent/UA40587C2/uk unknown
- 1992-08-12 SK SK135-94A patent/SK281252B6/sk not_active IP Right Cessation
- 1992-08-12 AT AT92918356T patent/ATE226073T1/de active
- 1992-08-12 DK DK92918356T patent/DK0641203T3/da active
- 1992-08-12 ES ES92918356T patent/ES2185617T3/es not_active Expired - Lifetime
- 1992-08-12 AU AU24756/92A patent/AU667824B2/en not_active Ceased
- 1992-08-12 BR BR9206443A patent/BR9206443A/pt not_active IP Right Cessation
- 1992-08-12 PL PL92302397A patent/PL177234B1/pl unknown
- 1992-08-12 EP EP92918356A patent/EP0641203B1/en not_active Expired - Lifetime
- 1992-08-12 RO RO94-00225A patent/RO113643B1/ro unknown
- 1992-08-12 HU HU9400413A patent/HU225048B1/hu unknown
- 1992-08-12 CZ CZ94311A patent/CZ281635B6/cs not_active IP Right Cessation
- 1992-08-12 CA CA002115170A patent/CA2115170C/en not_active Expired - Lifetime
- 1992-08-12 JP JP5504405A patent/JPH07500579A/ja active Pending
- 1992-08-12 DE DE69232817T patent/DE69232817T2/de not_active Expired - Lifetime
- 1992-08-12 WO PCT/US1992/006734 patent/WO1993003722A1/en not_active Ceased
- 1992-08-13 MA MA22915A patent/MA22626A1/fr unknown
- 1992-08-14 MX MX9204737A patent/MX9204737A/es active IP Right Grant
- 1992-08-14 AP APAP/P/1995/000742A patent/AP527A/en active
- 1992-08-14 ZA ZA926133A patent/ZA926133B/xx unknown
- 1992-08-14 AP APAP/P/1992/000416A patent/AP525A/en active
- 1992-08-14 MY MYPI92001466A patent/MY110205A/en unknown
- 1992-08-14 CN CN92110883A patent/CN1036396C/zh not_active Expired - Lifetime
- 1992-08-14 PT PT100779A patent/PT100779B/pt not_active IP Right Cessation
- 1992-08-14 AP APAP/P/1995/000741A patent/AP526A/en active
- 1992-08-14 NZ NZ243966A patent/NZ243966A/en unknown
- 1992-08-14 IL IL10281392A patent/IL102813A/en not_active IP Right Cessation
- 1992-08-20 TW TW081106595A patent/TW234690B/zh not_active IP Right Cessation
-
1994
- 1994-02-10 OA OA60471A patent/OA09884A/en unknown
- 1994-02-11 NO NO940476A patent/NO305172B1/no not_active IP Right Cessation
- 1994-02-11 FI FI940642A patent/FI114796B/fi not_active IP Right Cessation
- 1994-02-11 BG BG98454A patent/BG61593B1/bg unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP9200416A0 (en) | Imidazolyl-alkenoic acids | |
| DE59207898D1 (en) | Handhobelmaschine | |
| ZA922420B (en) | Grf-analogs ii | |
| DE59208556D1 (en) | N-aminopyridonfarbstoffe | |
| GB9325558D0 (en) | Percaboxylic acids | |
| EP0563238A4 (en) | Imidazolyl-alkenoic acids | |
| DE69208351D1 (en) | Halovinylderivate | |
| ZA919058B (en) | Sulfimidoperoxycarboxylic acids | |
| IE900337L (en) | Heteroaryl-1-alkyl-pyrrole-2-carboxylic acids | |
| IE900338L (en) | Heteroaryl-1-alkyl-pyrrole-2-carboxylic acids | |
| IE900361L (en) | Saccharoascorbic acids | |
| ZW9390A1 (en) | Imidazolyl-alkenoic acids | |
| ZA933757B (en) | Cyclopentane-and-pentene-beta-amino acids | |
| AU213P (en) | MOONBEAM Galtonia candicans | |
| DE59207864D1 (en) | Koagulationssonde | |
| CA69416S (en) | Orgnizer | |
| CA68731S (en) | Moneybox | |
| AU204P (en) | NIRIBI Chamelaucium uncinatum | |
| AU205P (en) | TARANNA Danthonia richardsonii | |
| AU206P (en) | BUNDERRA Danthonia linkii | |
| CA68724S (en) | Mobilier-jeu pedagogique | |
| CA68506S (en) | Pom-pom | |
| AU352P (en) | TRIUMPHANT Chamelaucium uncinatum | |
| DE59209753D1 (en) | Spurregelkreis | |
| GB9121278D0 (en) | Ester |